Funding Gap For Life Science Cos. Is Still A Problem
During the first half of 2013, midstage life sciences companies have seen more initial public offerings than any year since 2004. However, for startup life sciences companies, the capital markets are...To view the full article, register now.
Already a subscriber? Click here to view full article